Skip to main content
SpringerLink
Log in
Book cover

Laboratory Hemostasis pp 99–110Cite as

Testing for Acquired Platelet Disorders

  • Chapter
  • First Online:

  • 1661 Accesses

Abstract

Acquired platelet disorders can be broadly categorized into disorders of platelet number and disorders of platelet function, though there can be overlap (e.g., myeloproliferative disorders). The hematology laboratory traditionally assesses platelet number using automated hematology analyzers, with targeted confirmation by manual counting. Platelet antibody assays may be performed by the immunology and/or coagulation laboratories, or by the transfusion service. Platelet function testing has traditionally been performed by special coagulation laboratories using platelet-rich plasma or whole blood platelet aggregation. However, new platelet function analyzers are being marketed as potential substitutes for traditional platelet aggregometry (see Chap. 3).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Morris MW, Davey FR. Basic examination of blood. In: Henry JB, editor. Clinical diagnosis and management by laboratory methods. 20th ed. Philadelphia: W.B. Saunders Company; 2001. p. 479–517.

    Google Scholar 

  2. International Council for Standardization in Haematology Expert Panel on Cytometry; International Society of Laboratory Hematology Task Force on Platelet Counting. Platelet counting by the RBC/platelet ratio method. A reference method. Am J Clin Pathol. 2001;115:460–4.

    Article  Google Scholar 

  3. Groner W, Simson E. Practical guide to modern hematology analyzers. New York: Wiley; 1995.

    Google Scholar 

  4. Pinkowski R. Difference between impedance and optical platelet count methods in patients with microcytosis of red blood cells. Lab Hematol. 1999;5:22–7.

    Google Scholar 

  5. Sandhaus LM, Osei ES, Agrawal NN, et al. Platelet counting by the coulter LH 750, sysmex XE 2100, and the advia 120: a comparative analysis using the RBC/platelet ratio reference method. Am J Clin Pathol. 2002;118:235–41.

    Article  PubMed  Google Scholar 

  6. Segal HC, Briggs C, Kunka SJ, et al. Accuracy of platelet counting haematology analyzers in severe thrombocytopenia and potential impact on platelet transfusion. Br J Haematol. 2005;128:520–5.

    Article  PubMed  CAS  Google Scholar 

  7. Steele BW, Wu N, Whitcomb C. White blood cell and platelet counting performance by hematology analyzers: a critical evaluation. Lab Hematol. 2001;7:255–66.

    CAS  Google Scholar 

  8. Kunz D, Kunz WS, Scott CS, et al. Automated CD61 immunoplatelet analysis of thrombocytopenic samples. Br J Haematol. 2001;112:584–92.

    Article  PubMed  CAS  Google Scholar 

  9. De la Salle BJ, McTaggart PN, Briggs C, et al. The accuracy of platelet counting in thrombocytopenic blood sample distributed by the UK National External Quality Assessment Scheme for General Haematology. Am J Clin Pathol. 2012;137:65–74.

    Article  PubMed  Google Scholar 

  10. Hong KH, Kim MJ, Lee KW, et al. Platelet count evaluation using three automated haematology analysers compared with the immunoplatelet reference method, and estimation of possible inadequate platelet transfusion. Int J Lab Hematol. 2008;31:298–306.

    Article  PubMed  Google Scholar 

  11. Gulati G, Asselta A, Chen C. Using a vortex to disaggregate platelet clumps. Lab Med. 1997;28:665–7.

    Google Scholar 

  12. Saito S, Ota M, Komatsu Y, et al. Serologic analysis of three cases of neonatal alloimmune thrombocytopenia associated with HLA antibodies. Transfusion. 2003;43:908–17.

    Article  PubMed  Google Scholar 

  13. Chong BH, Keng TB. Advances in the diagnosis of idiopathic thrombocytopenic purpura. Semin Hematol. 2000;37:249–60.

    Article  PubMed  CAS  Google Scholar 

  14. Linkins L, Dans AL, Moores LK, et al. Treatment and prevention of heparin-induced thrombocytopenia. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e495s–530.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  15. Warkentin TE. Platelet count monitoring and laboratory testing for heparin-induced thrombocytopenia. Arch Pathol Lab Med. 2002;126:1415–23.

    PubMed  Google Scholar 

  16. Francis JL. A critical evaluation of assays for detecting antibodies to the heparin-PF4 complex. Semin Thromb Hemost. 2004;30:359–68.

    Article  PubMed  CAS  Google Scholar 

  17. Althaus K, Hron G, Strobel U. Evaluation of automated immunoassays in the diagnosis of heparin induced thrombocytopenia. Thromb Res. 2013;131:e85–90.

    Article  PubMed  CAS  Google Scholar 

  18. Watson H, Davidson S, Keeling D. Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition. Br J Haematol. 2012;159:528–40.

    PubMed  Google Scholar 

  19. Warkentin TE, Greinacher A, Gruel Y, et al. Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis. J Thromb Haemost. 2011;9:2498–500.

    Article  PubMed  CAS  Google Scholar 

  20. Warkentin TE, Sheppard JI. Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin. Blood. 2014;123:2485–93.

    Article  PubMed  CAS  Google Scholar 

  21. Neunert C, Lim W, Crowther M, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;4190–4207.

    Google Scholar 

  22. Schafer AI. Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia. Blood. 2006;107:4214–22.

    Article  PubMed  CAS  Google Scholar 

  23. Noris M, Remuzzi G. Uremic bleeding: closing the circle after 30 years of controversies? Blood. 1999;94:2569–74.

    PubMed  CAS  Google Scholar 

  24. Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost. 1990;16:1–20.

    Article  PubMed  CAS  Google Scholar 

  25. Escolar G, Cases A, Vinas M, et al. Evaluation of acquired platelet dysfunction in uremic and cirrhotic patients using the platelet function analyzer (PFA-100™): influence of hematocrit elevation. Haematologica. 1999;84:614–9.

    PubMed  CAS  Google Scholar 

  26. Davis CL, Chandler WL. Thromboelastography for the prediction of bleeding after transplant renal biopsy. J Am Soc Nephrol. 1995;1250–55.

    Google Scholar 

  27. Kasmeridis C, Apostolakis S, Lip GYH. Aspirin and aspirin resistance in coronary disease. Curr Opin Pharmacol. 2013;13:242–50.

    Article  PubMed  CAS  Google Scholar 

  28. Krasopoulos G, Brister SJ, Beattie WS, et al. Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ. 2008;336:195–8.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Gum PA, Kottke-Marchant K, Welsh PA, et al. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol. 2003;41:961–5.

    Article  PubMed  CAS  Google Scholar 

  30. Douketis JD, Spyropoulos MD, Spencer FA, et al. Perioperative management of antithrombotic therapy. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e326S–50.

    PubMed  CAS  PubMed Central  Google Scholar 

  31. Michelson AD, Cattaneo M, Eikelboom JW, et al. Aspirin resistance: position paper of the working group on aspirin resistance. J Thromb Haemost. 2005;3:1309–11.

    Article  PubMed  CAS  Google Scholar 

  32. Ferraris VA, Saha SP, Oestreich JH, et al. 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg. 2012;94:1761–81.

    Article  PubMed  Google Scholar 

  33. Tantry US, Bonello L, Aradi D, et al. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol. 2013;62:2261–73.

    Article  PubMed  CAS  Google Scholar 

  34. Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med. 2004;1873–81.

    Google Scholar 

  35. Janssen PWA, ten Berg JM, Hackeng CM. The use of platelet function testing in PCI and CABG patients. Blood Rev. 2014;28:109–21.

    Article  PubMed  Google Scholar 

  36. Likosky DS, FitzGerald DC, Groom RC, et al. Effect of the perioperative blood transfusion and blood conservation in cardiac surgery clinical practice guidelines of the Society of Thoracic surgeons and the Society of Cardiovascular Anesthesiologists upon clinical practices. Anesth Analg. 2010;111:316–23.

    Article  PubMed  Google Scholar 

  37. Biancari F, Mikkola R, Heikkinen J, et al. Individual surgeon’s impact on the risk of re-exploration for excessive bleeding after coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 2012;26:550–6.

    Article  PubMed  Google Scholar 

  38. Nuttall GA, Oliver WC, Santrach PJ, et al. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology. 2001;94:773–81.

    Article  PubMed  CAS  Google Scholar 

  39. Avidan MS, Alcock EL, Da Fonseca J, et al. Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth. 2004;92:178–86.

    Article  PubMed  CAS  Google Scholar 

  40. Weber CF, Gorlinger K, Meininger D, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology. 2012;117:531–47.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT, USA

    Christopher M. Lehman MD

  2. Hospital Clinical Laboratories, ARUP Laboratories, Salt Lake City, UT, USA

    Christopher M. Lehman MD

Authors
  1. Christopher M. Lehman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher M. Lehman MD .

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Lehman, C.M. (2015). Testing for Acquired Platelet Disorders. In: Laboratory Hemostasis. Springer, Cham. https://doi.org/10.1007/978-3-319-08924-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-08924-9_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-08923-2

  • Online ISBN: 978-3-319-08924-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation